1. Home
  2. OVID vs KUKE Comparison

OVID vs KUKE Comparison

Compare OVID & KUKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • KUKE
  • Stock Information
  • Founded
  • OVID 2014
  • KUKE 2002
  • Country
  • OVID United States
  • KUKE China
  • Employees
  • OVID N/A
  • KUKE N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • KUKE Other Consumer Services
  • Sector
  • OVID Health Care
  • KUKE Real Estate
  • Exchange
  • OVID Nasdaq
  • KUKE Nasdaq
  • Market Cap
  • OVID 88.9M
  • KUKE 86.8M
  • IPO Year
  • OVID 2017
  • KUKE 2021
  • Fundamental
  • Price
  • OVID $1.27
  • KUKE $1.61
  • Analyst Decision
  • OVID Strong Buy
  • KUKE
  • Analyst Count
  • OVID 4
  • KUKE 0
  • Target Price
  • OVID $3.13
  • KUKE N/A
  • AVG Volume (30 Days)
  • OVID 1.5M
  • KUKE 34.6K
  • Earning Date
  • OVID 11-11-2025
  • KUKE 10-15-2025
  • Dividend Yield
  • OVID N/A
  • KUKE N/A
  • EPS Growth
  • OVID N/A
  • KUKE N/A
  • EPS
  • OVID N/A
  • KUKE N/A
  • Revenue
  • OVID $6,651,000.00
  • KUKE $9,442,397.00
  • Revenue This Year
  • OVID $708.13
  • KUKE N/A
  • Revenue Next Year
  • OVID N/A
  • KUKE N/A
  • P/E Ratio
  • OVID N/A
  • KUKE N/A
  • Revenue Growth
  • OVID 1070.95
  • KUKE N/A
  • 52 Week Low
  • OVID $0.24
  • KUKE $1.45
  • 52 Week High
  • OVID $1.47
  • KUKE $10.00
  • Technical
  • Relative Strength Index (RSI)
  • OVID 55.01
  • KUKE 39.81
  • Support Level
  • OVID N/A
  • KUKE $1.60
  • Resistance Level
  • OVID $1.35
  • KUKE $2.04
  • Average True Range (ATR)
  • OVID 0.10
  • KUKE 0.17
  • MACD
  • OVID -0.07
  • KUKE 0.02
  • Stochastic Oscillator
  • OVID 93.78
  • KUKE 20.56

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About KUKE Kuke Music Holding Limited

Kuke Music Holding Ltd provides classical music licensing, subscription, and education services in China. The company licenses its music content to online music entertainment platforms, such as Tencent Music Entertainment Group, digital music service providers, such as NetEase Cloud Music, as well as film and TV production companies, airlines, and smart hardware companies. Users can access the platform through the website, mobile app, and smart music devices.

Share on Social Networks: